Who Paid My Doc
FebriDx
ClinicalTrials.gov NCT02018198
Research payments
$729,099
Through program year 2022, $729,099 in research payments was reported against FebriDx, across 58 payments, paid by Rapid Pathogen Screening, Inc..
- Paid by
- Rapid Pathogen Screening, Inc.
- ClinicalTrials.gov
- NCT02018198
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $1,109 | 1 |
| 2020 | Research | $639,709 | 49 |
| 2019 | Research | $88,280 | 8 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jeffrey Harris Greenville, SC Named on 9 payments
- Robert Birkhahn Brooklyn, NY Named on 7 payments
- Jeffrey Rosen Coral Gables, FL Named on 4 payments
- Natasha Ballard Chattanooga, TN Named on 4 payments
- Stephan Sharp Nashville, TN Named on 3 payments
- Michael Filbin Lawrence, MA Named on 3 payments
- Darrell Herrington San Angelo, TX Named on 3 payments
- Eliot Godofsky Bradenton, FL Named on 2 payments
- Marc Mickiewicz Nashville, TN Named on 2 payments
- Michael Ward Chicago, IL Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.